generic speaker image
John McCulloch - MaRS Discovery District. Toronto, ON, CA

John McCulloch John McCulloch

Founder & Managing Director | Burloch Group Inc.

Toronto, ON, CANADA

Engaging and knowledgeable speaker with deep expertise in biotechnology investment.





loading image loading image loading image


Entrepreneurship 101 2010/11 - Meet the Entrepreneurs - Life Sciences & Health Care MaRS Future of Medicine 2010 Conference Promo New Models of Innovation in Life Sciences




John has worked for over 25 years building value in the life sciences sector. As the Founder and Managing Director of Burloch Group, John helps connect innovators, developers and financiers to create solutions for unmet medical needs.

Prior to Burloch, John worked with emerging life sciences ventures across Ontario as a Senior Advisor at MaRS. He founded and managed the highly successful MaRS Future of Medicine™ event series that showcased leading biotech innovators.

John has also served as President and COO of Aggregate Therapeutics Inc - a Canadian stem cell "mutual fund" and from 1994 to 2006 he worked for Drug Royalty Corporation Inc (now DRI Capital) where he served as Vice President, Medical & Scientific Affairs. He completed 20 investments (totaling $250 million) with excellent returns and subsequently assisted in a $300 million investment as an independent advisor.

John holds a PhD in immunology from the University of London and is a graduate of the Canadian Securities Course.

Industry Expertise (3)

Biotechnology Investment Management Pharmaceuticals

Areas of Expertise (4)

Biotechnology Pharmaceuticals Innovation Investment

Accomplishments (3)

President & COO, Aggregate Therapeutics (professional)

Vice President, Medical and Scientific Affairs, Drug Royalty Corporation (professional)

Senior Advisor, Life Sciences & Healthcare, MaRS (professional)



Education (3)

University of London: PhD, Immunology 1991

University of Glasgow: B.Sc. (Hons), Immunology 1986

Canadian Securities Institute: Canadian Securities Certificate, Investment 1994

Event Appearances (3)

Stem cell commercialization – the Canadian experience

Progress to Therapy 2012  Glasgow, Scotland


Commercializing Life Sciences in the UK

Osgoode Hall Law School  Toronto, ON


Building great companies from Canadian technology

IEW 2010  Biopolis, Singapore


Sample Talks (1)

Top 10 Mistakes to Avoid for Biotech Entrepreneurs

Find out the common mistakes biotech start-ups make and, more importantly, how to avoid them.



  • Keynote
  • Moderator
  • Panelist
  • Workshop Leader
  • Host/MC


500 to 3500